{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:51:04Z","timestamp":1774263064890,"version":"3.50.1"},"reference-count":32,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100005001","name":"Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran","doi-asserted-by":"publisher","award":["OG-0043"],"award-info":[{"award-number":["OG-0043"]}],"id":[{"id":"10.13039\/501100005001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMM"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Breast cancer is considered the most frequent type of cancer\nin women with high mortality worldwide, and most importantly, it is the second most\ncommon cancer. However, some breast cancer-related risk factors remain unknown.\nSo, the current study was designed to evaluate the effect of Toxocara canis on the\nbiomarkers correlated with proliferation, apoptosis, inflammation, and angiogenesis in\n4T1 tumor-bearing mice infected with Toxocara canis for the first time.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Mice were categorized into four groups: A) control, B) treated with 4T1+\nToxocara canis, C) treated with Toxocara canis, and D) treated with 4T1. The expression\nof Ki-67 and P53 was then evaluated by using the immunohistochemical technique.\nIn addition, the levels of transforming growth factor-\u03b2, Interferon gamma-\u03b3, Interleukin\n10, tumor necrosis factor-\u03b1 and vascular endothelial growth factor as well as\nanti-Toxocara canis IgG were determined using the enzyme-linked immunosorbent\nassay method.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The expression of Ki-67 was significantly increased in the 4T1+ Toxocara\ncanis group than control and Toxocara canis groups (P &lt; 0.001 and P &lt; 0.001, respectively).\nMoreover, a significant decrease in P53 was found in the 4T1+ Toxocara canis\ngroup than in the control and Toxocara canis groups (P &lt; 0.001 and P &lt; 0.001, respectively).\nAlso, the 4T1+ Toxocara canis group significantly reduced the expression of\nP53 more than 4T1 tumor-bearing mice (P = 0.005). In addition, the 4T1+ Toxocara\ncanis group had an increasing tumor necrosis factor-\u03b1 and vascular endothelial growth\nfactor than controls (P = 0.004 and P = 0.002, respectively). Furthermore, a significant\nreduction in Interleukin 10 was found in the 4T1+ Toxocara canis group than in the\ncontrol group (P = 0.004).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Our findings showed that Toxocara canis could probably increase the\npotential of breast cancer by reducing P53 in 4T1 tumor-bearing mice infected with\nToxocara canis more than other groups.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1566524023666230320103506","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T11:42:57Z","timestamp":1679485377000},"page":"335-343","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Toxocara Canis Increases the Potential of Breast Cancer by\nReducing the Expression of the P53 Protein"],"prefix":"10.2174","volume":"24","author":[{"given":"Forough","family":"Kazemi","sequence":"first","affiliation":[{"name":"Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"},{"name":"Department\nof Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemen","family":"Moradi-Sardareh","sequence":"additional","affiliation":[{"name":"Department of Basic Sciences, Asadabad School of Medical Sciences, Asadabad, Iran"},{"name":"Biomad Company,\nOslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Arjmand","sequence":"additional","affiliation":[{"name":"Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur\nUniversity of Medical Sciences, Ahvaz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Tavalla","sequence":"additional","affiliation":[{"name":"Department\nof Parasitology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"},{"name":"Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur\nUniversity of Medical Sciences, Ahvaz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Amari","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Research Center, Medical Basic\nSciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"},{"name":"Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz,\nIran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bahman","family":"Cheraghian","sequence":"additional","affiliation":[{"name":"Alimentary Tract Research Center, Clinical Sciences Research Institute, Department of Biostatistics\nand Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"Bray F.","year":"2018","unstructured":"Bray F.; Ferlay J.; Soerjomataram I.; Siegel R.L.; Torre L.A.; Jemal A.; Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2018,68(6),394-424","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/iub.2305","volume":"72","author":"Sadegh-Nejadi S.","year":"2020","unstructured":"Sadegh-Nejadi S.; Afrisham R.; Emamgholipour S.; Influence of plasma circulating exosomes obtained from obese women on tumorigenesis and tamoxifen resistance in MCF \u20107 cells. IUBMB Life  2020,72(9),1930-1940","journal-title":"IUBMB Life"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3389\/fonc.2020.00736","volume":"10","author":"Ruiz-Manzano R.A.","year":"2020","unstructured":"Ruiz-Manzano R.A.; Palacios-Arreola M.I.; Hern\u00e1ndez-Cervantes R.; Potential novel risk factor for breast cancer: Toxocara canis infection increases tumor size due to modulation of the tumor immune microenvironment. Front Oncol  2020,10,736","journal-title":"Front Oncol"},{"key":"ref=4","first-page":"73","volume":"1856","author":"Barnard M.E.","year":"2015","unstructured":"Barnard M.E.; Boeke C.E.; Tamimi R.M.; Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim Biophys Acta  2015,1856(1),73-85","journal-title":"Biochim Biophys Acta"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"10573","DOI":"10.1038\/s41598-017-10135-1","volume":"7","author":"Palacios-Arreola M.I.","year":"2017","unstructured":"Palacios-Arreola M.I.; Nava-Castro K.E.; R\u00edo-Araiza V.H.D.; P\u00e9rez-S\u00e1nchez N.Y.; Morales-Montor J.; A single neonatal administration of Bisphenol A induces higher tumour weight associated to changes in tumour microenvironment in the adulthood. Sci Rep  2017,7(1),10573","journal-title":"Sci Rep"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12029-020-00518-5","volume":"52","author":"Alipour M.","year":"2021","unstructured":"Alipour M.; Molecular mechanism of Helicobacter pylori-induced gastric cancer. J Gastrointest Cancer  2021,52(1),23-30","journal-title":"J Gastrointest Cancer"},{"key":"ref=7","first-page":"e21331","volume":"14","author":"Arcia Franchini A.P.","year":"2022","unstructured":"Arcia Franchini A.P.; Iskander B.; Anwer F.; The role of chlamydia trachomatis in the pathogenesis of cervical cancer. Cureus  2022,14(1),e21331","journal-title":"Cureus"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"e0186860","DOI":"10.1371\/journal.pone.0186860","volume":"12","author":"She Y.","year":"2017","unstructured":"She Y.; Nong X.; Zhang M.; Wang M.; Epstein-Barr virus infection and oral squamous cell carcinoma risk: A meta-analysis. PLoS One  2017,12(10),e0186860","journal-title":"PLoS One"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/apm.13016","volume":"128","author":"J\u00f8rgensen K.R.","year":"2020","unstructured":"J\u00f8rgensen K.R.; Jensen J.B.; Human papillomavirus and urinary bladder cancer revisited. Acta Pathol Microbiol Scand Suppl  2020,128(2),72-79","journal-title":"Acta Pathol Microbiol Scand Suppl"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e609","DOI":"10.1016\/S2214-109X(16)30143-7","volume":"4","author":"Plummer M.","year":"2016","unstructured":"Plummer M.; de Martel C.; Vignat J.; Ferlay J.; Bray F.; Franceschi S.; Global burden of cancers attributable to infections in 2012: A synthetic analysis. Lancet Glob Health  2016,4(9),e609-e616","journal-title":"Lancet Glob Health"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1002\/ijc.30028","volume":"138","author":"Machicado C.","year":"2016","unstructured":"Machicado C.; Marcos L.A.; Carcinogenesis associated with parasites other than schistosoma, opisthorchis and clonorchis: A systematic review. Int J Cancer  2016,138(12),2915-2921","journal-title":"Int J Cancer"},{"key":"ref=12","first-page":"876585","volume":"2013","author":"Botelho M.C.","year":"2013","unstructured":"Botelho M.C.; Veiga I.; Oliveira P.A.; Carcinogenic ability of Schistosoma haematobium possibly through oncogenic mutation of KRAS gene. Adv Cancer Res Treat  2013,2013,876585","journal-title":"Adv Cancer Res Treat"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"e1006649","DOI":"10.1371\/journal.ppat.1006649","volume":"13","author":"Pastille E.","year":"2017","unstructured":"Pastille E.; Frede A.; McSorley H.J.; Intestinal helminth infection drives carcinogenesis in colitis-associated colon cancer. PLoS Pathog  2017,13(9),e1006649","journal-title":"PLoS Pathog"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1179\/136485910X12607012373957","volume":"104","author":"Rubinsky-Elefant G.","year":"2010","unstructured":"Rubinsky-Elefant G.; Hirata C.E.; Yamamoto J.H.; Ferreira M.U.; Human toxocariasis: Diagnosis, worldwide seroprevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol  2010,104(1),3-23","journal-title":"Ann Trop Med Parasitol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2174\/1871526520666200715100433","volume":"21","author":"Kazemi F.","year":"2021","unstructured":"Kazemi F.; Arjmand R.; Fallahizadeh S.; Tavalla M.; Comparison of the detection of Toxocara spp. in the soils of public parks of Ahvaz (southwest of Iran) by PCR and loop-mediated isothermal amplification (LAMP). Infect Disord Drug Targets  2021,21(3),375-383","journal-title":"Infect Disord Drug Targets"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.actatropica.2018.07.017","volume":"187","author":"Moura M.Q.","year":"2018","unstructured":"Moura M.Q.; Macedo M.R.P.; Terto W.D.S.; Detection of Toxocara canis DNA in tissues of experimentally infected mice. Acta Trop  2018,187,51-56","journal-title":"Acta Trop"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1017\/S0022149X16000559","volume":"91","author":"Zibaei M.","year":"2017","unstructured":"Zibaei M.; Sadjjadi S.M.; Maraghi S.; The occurrence of Toxocara species in naturally infected broiler chickens revealed by molecular approaches. J Helminthol  2017,91(5),633-636","journal-title":"J Helminthol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e12672","DOI":"10.1111\/pim.12672","volume":"41","author":"Ruiz-Manzano R.A.","year":"2019","unstructured":"Ruiz-Manzano R.A.; Hern\u00e1ndez-Cervantes R.; Del R\u00edo-Araiza V.H.; Palacios-Arreola M.I.; Nava-Castro K.E.; Morales-Montor J.; Immune response to chronic Toxocara canis infection in a mice model. Parasite Immunol  2019,41(12),e12672","journal-title":"Parasite Immunol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2174\/1871526520666191231123159","volume":"21","author":"Saki J.","year":"2021","unstructured":"Saki J.; Mowla K.; Arjmand R.; Kazemi F.; Fallahizadeh S.; Prevalence of Toxoplasma gondii and Toxocara canis among myositis patients in the Southwest of Iran. Infect Disord Drug Targets  2021,21(1),43-48","journal-title":"Infect Disord Drug Targets"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF00285178","volume":"83","author":"Schonk D.M.","year":"1989","unstructured":"Schonk D.M.; Kuijpers H.J.H.; van Drunen E.; Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10. Hum Genet  1989,83(3),297-299","journal-title":"Hum Genet"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1267\/ahc.09030","volume":"42","author":"Shirendeb U.","year":"2009","unstructured":"Shirendeb U.; Hishikawa Y.; Moriyama S.; Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in Japan, Mongolia, and Myanmar. Acta Histochem Cytochem  2009,42(6),181-190","journal-title":"Acta Histochem Cytochem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"W128","DOI":"10.1093\/nar\/gkn195","author":"Hooghe B","year":"2008","unstructured":"Hooghe B; Hulpiau P; van Roy F; De Bleser P.; ConTra: A promoter alignment analysis tool for identification of transcription factor binding sites across species. Nucleic Acids Res\t 36(Web Server issue)  2008(Suppl. 2),W128-32","journal-title":"Nucleic Acids Res\t 36(Web Server issue)"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.3390\/cancers13174455","volume":"13","author":"Davey M.G.","year":"2021","unstructured":"Davey M.G.; Hynes S.O.; Kerin M.J.; Miller N.; Lowery A.J.; Ki-67 as a prognostic biomarker in invasive breast cancer. Cancers  2021,13(17),4455","journal-title":"Cancers"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.celrep.2018.06.110","volume":"24","author":"Miller I.","year":"2018","unstructured":"Miller I.; Min M.; Yang C.; Ki67 is a graded rather than a binary marker of proliferation versus quiescence. Cell Rep  2018,24(5),1105-12.e5","journal-title":"Cell Rep"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000345321","volume":"84","author":"Ishihara M.","year":"2013","unstructured":"Ishihara M.; Mukai H.; Nagai S.; Retrospective analysis of risk factors for central nervous system metastases in operable breast cancer: Effects of biologic subtype and Ki67 overexpression on survival. Oncology  2013,84(3),135-140","journal-title":"Oncology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e47068","DOI":"10.1371\/journal.pone.0047068","volume":"7","author":"Sorbye S.W.","year":"2012","unstructured":"Sorbye S.W.; Kilvaer T.K.; Valkov A.; Prognostic impact of Jab1, p16, p21, p62, Ki67 and Skp2 in soft tissue sarcomas. PLoS One  2012,7(10),e47068","journal-title":"PLoS One"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4048\/jbc.2014.17.1.40","volume":"17","author":"Kim K.I.","year":"2014","unstructured":"Kim K.I.; Lee K.H.; Kim T.R.; Chun Y.S.; Lee T.H.; Park H.K.; Ki-67 as a predictor of response to neoadjuvant chemotherapy in breast cancer patients. J Breast Cancer  2014,17(1),40-46","journal-title":"J Breast Cancer"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0092-8674(79)90293-9","volume":"17","author":"Linzer D.I.H.","year":"1979","unstructured":"Linzer D.I.H.; Levine A.J.; Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell  1979,17(1),43-52","journal-title":"Cell"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.3390\/cancers14133145","volume":"14","author":"Zhao L.","year":"2022","unstructured":"Zhao L.; Sanyal S.; p53 isoforms as cancer biomarkers and therapeutic targets. Cancers  2022,14(13),3145","journal-title":"Cancers"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"188556","DOI":"10.1016\/j.bbcan.2021.188556","volume":"1876","author":"Hern\u00e1ndez B.L.J.","year":"2021","unstructured":"Hern\u00e1ndez B.L.J.; El-Deiry W.S.; Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochim Biophys Acta Rev Cancer  2021,1876(1),188556","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/cdd.2017.180","volume":"25","author":"Baugh E.H.","year":"2018","unstructured":"Baugh E.H.; Ke H.; Levine A.J.; Bonneau R.A.; Chan C.S.; Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ  2018,25(1),154-160","journal-title":"Cell Death Differ"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1128\/CMR.05040-11","volume":"25","author":"McSorley H.J.","year":"2012","unstructured":"McSorley H.J.; Maizels R.M.; Helminth infections and host immune regulation. Clin Microbiol Rev  2012,25(4),585-608","journal-title":"Clin Microbiol Rev"}],"container-title":["Current Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524023666230320103506","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/214729\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1566524023666230320103506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T09:23:58Z","timestamp":1711704238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/214729\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1566524023666230320103506","relation":{},"ISSN":["1566-5240"],"issn-type":[{"value":"1566-5240","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}